Heading: |
Antimicrobials: Drug Resistance |
Question ID: |
1759538 |
UIN: |
HL4484 |
House: |
Lords |
Date tabled: |
2025-01-28 |
Asking Member ID: |
4719 |
Asking Member display name: |
Baroness Bennett of Manor Castle
|
Asking Member handle: |
natalieben
|
Asking Member Twitter reference: |
@natalieben
|
Member interest: |
false |
Question text: |
To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 13 January (HC3975) what assessment they have made of the level of compliance with the recommendation in the Joint Royal College of Surgeons of England and Medicines and |
Is named day: |
false |
Date of holding answer: |
|
Date answered: |
2025-02-04 |
Date answer corrected: |
|
Is holding answer: |
false |
Is correcting answer: |
false |
Answering Member ID: |
347 |
Answering Member display name: |
Baroness Merron
|
Answering Member handle: |
|
Answering Member Twitter reference: |
Baroness Merron
|
Correcting Member ID: |
|
Correcting Member display name: |
|
Correcting Member handle: |
|
Correcting Member Twitter reference: |
|
Answer text: |
The Medicines and Healthcare products Regulatory Agency (MHRA), as the regulator for medicines and medical devices in the United Kingdom, continues to recommend the use of licensed medicines. Use of an appropriately authorised product, in accordance with ... |
Original answer text: |
|
Comparable answer text: |
|
Answering body ID: |
17 |
Answering body name: |
Department of Health and Social Care |
Tweeted: |
true |